On-a-chip Biosensing Based on All-Dielectric Nanoresonators
METADATA ONLY
Loading...
Author / Producer
Date
2017-07-12
Publication Type
Journal Article
ETH Bibliography
no
Citations
Altmetric
METADATA ONLY
Data
Rights / License
Abstract
Nanophotonics has become a key enabling technology in biomedicine with great promises in early diagnosis and less invasive therapies. In this context, the unique capability of plasmonic noble metal nanoparticles to concentrate light on the nanometer scale has widely contributed to biosensing and enhanced spectroscopy. Recently, high-refractive index dielectric nanostructures featuring low loss resonances have been proposed as a promising alternative to nanoplasmonics, potentially offering better sensing performances along with full compatibility with the microelectronics industry. In this letter we report the first demonstration of biosensing with silicon nanoresonators integrated in state-of-the-art microfluidics. Our lab-on-a-chip platform enables detecting Prostate Specific Antigen (PSA) cancer marker in human serum with a sensitivity that meets clinical needs. These performances are directly compared with its plasmonic counterpart based on gold nanorods. Our work opens new opportunities in the development of future point-of-care devices toward a more personalized healthcare. © 2017 American Chemical Society.
Permanent link
Publication status
published
External links
Editor
Book title
Journal / series
Volume
17 (7)
Pages / Article No.
4421 - 4426
Publisher
American Chemical Society
Event
Edition / version
Methods
Software
Geographic location
Date collected
Date created
Subject
Bionanophotonics; Lab-on-chip; All-dielectric nanoresonators; Biosensing; Cancer; Silicon
Organisational unit
09698 - Quidant, Romain / Quidant, Romain